Intensive glucose therapy improves some markers

04/25/2013 | Healio

Older type 2 diabetes patients who underwent intensive glucose-lowering therapy attained better adiponectin, lipid and triglyceride levels at nine months, a study indicated. However, the intensive therapy did not appear to improve cardiovascular outcomes in patients, researchers reported in Diabetes Care.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA